A STUDY ON CLINICAL PROFILE AND OUTCOME OF VISUAL PARAMETERS OF OPTIC NEURITIS PATIENTS IN A TERTIARY EYE CARE CENTRE
DOI:
https://doi.org/10.22159/ajpcr.2023.v16i7.48208Keywords:
Optic neuritis, Multiple sclerosis, Recurrence rate, Centrocecal Scotoma, Bimodal, Visual field abnormalityAbstract
Introduction: Optic neuritis (ON) is the inflammation of the optic nerve secondary to autoimmune, infectious, or inflammatory conditions.
Objective: The objective is to study the clinical profile and changes in visual parameters after the treatment of patients with ON.
Methods: This prospective interventional research was done at the ophthalmology department of a tertiary eye care center. 36 cases diagnosed with ON have been analyzed, treated, and followed up for 1 year, for the type of clinical presentation, rate of recurrence, and changes in visual parameters.
Results: The prevalence rate was bimodal, more common among age groups between 46 and 55 years at 32% and age group 16–25 at 27%. A higher prevalence rate was seen in females in 63% of cases. The bilateral presentation was observed in 18%. 44% of cases presented as retrobulbar neuritis (RBN) whereas 56% were as papillitis. At 1 year follow up Optic disc edema suggestive of papillitis was seen in 17% of cases, normal disc with RBN in 44% and disc pallor in 32% discs. At the final follow-up after 1 year, 75% of patients could read maximum (10/13) color plates, 64% of cases showed standard contrast sensitivity and 47% showed normal visual field. VA of 6/60 or worse at presentation was seen in 53% cases and <6/12 in (84%) cases which improved to better than 6/12 in 58% cases and better than 6/60 in 67% cases at final follow up at 1 year. The most common visual field abnormality at presentation was generalized field constriction in (34%), central or centrocecal scotoma in (18%), hemianopia or quadrantanopia (12%), and enlarged blind spot in (06%) cases. During the final follow-up at 1 year, 22 cases (61%) showed normal field. Visual Field could not be tested in (30%) at presentation as vision was <3/60, although visual evoked potential was abnormal in all of 36 (100%) cases with mean P 100 latency being 128 ms. Furthermore, 3 (8%) cases demonstrated additional neurological symptoms till the final follow-up and were subsequently identified to be multiple sclerosis (MS). Recurrence rate was 08 (22%) within 1 year follow-up, of which 06 (17%) cases were clinically RBN and 02 (05%) were papillitis.
Conclusion: In our study, findings of clinical profile and visual outcomes of ON patients were different from that of Western studies as well as from those done previously in the Indian population, notably lesser prevalence of MS, although other differences were not very significant.
Downloads
References
Langer-Gould A, Zhang JL, Chung J, Yeung Y, Waubant E, Yao J. Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children. Neurology 2011;77:1143-8.
Banwell B, Kennedy J, Sadovnick D, Arnold DL, Magalhaes S, Wambera K, et al. Incidence of acquired demyelination of the CNS in Canadian children. Neurology 2009;72:232-9. doi: 10.1212/01. wnl.0000339482.84392.bd, PMID 19153370
Matiello M, Lennon VA, Jacob A, Pittock SJ, Lucchinetti CF, Wingerchuk DM, et al. NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 2008;70:2197-200.
Jarius S, Frederikson J, Waters P, Paul F, Akman-Demir G, Marignier R, et al. Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis. J Neurol Sci 2010;298:158-62. doi: 10.1016/j.jns.2010.07.011, PMID 20850793
Collinge JE, Sprunger DT. Update in pediatric optic neuritis. Curr Opin Ophthalmol 2013;24:448-52. doi: 10.1097/ICU.0b013e3283641b86, PMID 23872812
Bennett JL. Optic neuritis. Continuum (Minneap Minn) 2019;25:1236-64.
Wakakura M, Minei-Higa R, Oono S, Matsui Y, Tabuchi A, Kani K, et al. Baseline features of idiopathic optic neuritis as determined by a multicenter treatment trial in Japan. Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG). Jpn J Ophthalmol 1999;43:127-32. doi: 10.1016/s0021-5155(98)00072-0, PMID 10340795
Wang JC, Tow S, Aung T, Lim SA, Cullen JF. The presentation, aetiology, management and outcome of optic neuritis in an Asian population. Clin Exp Ophthalmol 2001;29:312-5. doi: 10.1046/j.1442- 9071.2001.00442.x, PMID 11720158
Woung LC, Lin CH, Tsai CY, Tsai MT, Jou JR, Chou P. Optic neuritis among national health insurance enrollees in Taiwan, 2000-2004. Neuroepidemiology 2007;29:250-4. doi: 10.1159/000112858, PMID 18176082
Lim SA, Goh KY, Tow S, Fu E, Wong TY, Seah A, et al. Optic neuritis in Singapore. Singapore Med J 2008;49:667-71. PMID 18830538
Menon V, Mehrotra A, Saxena R, Jaffery NF. Comparative evaluation of megadose methylprednisolone with dexamethasone for treatment of primary typical optic neuritis. Indian J Ophthalmol 2007;55:355-9. doi: 10.4103/0301-4738.33821, PMID 17699944
Sethi HS, Menon V, Sharma P, Khokhar S, Tandon R. Visual outcome after intravenous dexamethasone therapy for idiopathic optic neuritis in an Indian population: A clinical case series. Indian J Ophthalmol 2006;54:177-83. doi: 10.4103/0301-4738.27069, PMID 16921215
Rodriguez M, Siva A, Cross SA, O’Brien PC, Kurland LT. Optic neuritis: A population-based study in Olmsted County, Minnesota. Neurology 1995;45:244-50. doi: 10.1212/wnl.45.2.244, PMID 7854520
Ambika S, Padmalakshmi K, Venkatraman V, Noronha OV. Visual outcomes and clinical manifestations of pediatric optic neuritis in Indian population: An institutional study. J Neuroophthalmol 2018;38:462-5. doi: 10.1097/WNO.0000000000000646, PMID 29554001
Banwell B, Kennedy J, Sadovnick D, Arnold DL, Magalhaes S, Wambera K, et al. Incidence of acquired demyelination of the CNS in Canadian children. Neurology 2009;72:232-9. doi: 10.1212/01. wnl.0000339482.84392.bd, PMID 19153370
Lucchinetti CF, Kiers L, O’Duffy A, Gomez MR, Cross S, Leavitt JA, et al. Risk factors for developing multiple sclerosis after childhood optic neuritis. Neurology 1997;49:1413-8. doi: 10.1212/wnl.49.5.1413, PMID 9371931
Khadse R, Ravindran M, Pawar N, Maharajan P, Rengappa R. Clinical profile and neuroimaging in pediatric optic neuritis in Indian population: A case series. Indian J Ophthalmol 2017;65:242-5. doi: 10.4103/ijo. IJO_939_16, PMID 28440255
Singh D, Phuljhele S, Sharma R, Sax-ena R, Sharma P, Menon V. Clinical spectrum of pediatric optic neuritis in Indian children. Ophthalmol Open J 2017:20-6.
Wakakura M, Minei-Higa R, Oono S, Matsui Y, Tabuchi A, Kani K, et al. Baseline features of idiopathic optic neuritis as determined by a multicenter treatment trial in Japan. Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG). Jpn J Ophthalmol 1999;43:127-32. doi: 10.1016/s0021-5155(98)00072-0, PMID 10340795
Wang JC, Tow S, Aung T, Lim SA, Cullen JF. The presentation, aetiology, management and outcome of optic neuritis in an Asian population. Clin Exp Ophthalmol 2001;29:312-5. doi: 10.1046/j.1442- 9071.2001.00442.x, PMID 11720158
Saxena R, Phuljhele S, Menon V, Sharma P, Sinha A, Gadaginamath S, et al. Clinical profile and short-term outcomes of optic neuritis patients in India. Indian J Ophthalmol 2014;62:265-7. doi: 10.4103/0301- 4738.121131
Lin YC, Yen MY, Hsu WM, Lee HC, Wang AG. Low conversion rate to multiple sclerosis in idiopathic optic neuritis patients in Taiwan. Jpn J Ophthalmol 2006;50:170-5. doi: 10.1007/s10384-005-0281-1, PMID 16604395
Pokroy R, Modi G, Saffer D. Optic neuritis in an urban black African community. Eye (Lond) 2001;15:469-73. doi: 10.1038/eye.2001.157, PMID 11767021
Visual functions 5 years after optic neuritis: Experience of the optic neuritis treatment trial. The Optic Neuritis Study Group. Arch Ophthalmol 1997;115:1545-52. PMID 9400788
Published
How to Cite
Issue
Section
Copyright (c) 2023 anitamisra ANITA MISRA
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
